ATHX Athersys Inc.

1.56
-0.08  -5%
Previous Close 1.64
Open 1.64
Price To Book 6.24
Market Cap 233,650,923
Shares 149,776,233
Volume 701,211
Short Ratio
Av. Daily Volume 733,137

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2/3 enrollment commenced November 2017 (Japan).
Multistem - TREASURE (Japan)
Ischemic stroke
Phase 3 MASTERS-2 trial initiation announced July 31, 2018.
Multistem
Ischemic stroke
Phase 2 enrollment continues but reported May 2018 that enrollment is slower than expected.
Multistem
Acute myocardial infarction
Phase 2 ONE-BRIDGE commencement of enrolment announced April 23, 2019.
Multistem
Acute Respiratory Distress Syndrome

Latest News

  1. Athersys to Host Second Quarter Financial Results Call
  2. Aggie Square executive helps foster university startups
  3. Edited Transcript of ATHX earnings conference call or presentation 8-May-19 8:30pm GMT
  4. Athersys to Present at Jefferies 2019 Healthcare Conference
  5. Athersys to Participate in four Events at the International Society of Cell and Gene Therapy Conference
  6. Volatility 101: Should Athersys (NASDAQ:ATHX) Shares Have Dropped 25%?
  7. Athersys Presents Data From Its Acute Respiratory Distress Syndrome Clinical Trial at American Thoracic Society International Conference
  8. The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
  9. Here's Why Athersys Rose as Much as 15.2% Today
  10. Athersys (ATHX) Q1 2019 Earnings Call Transcript
  11. Athersys Reports First Quarter 2019 Results
  12. Athersys, Inc. to Host Earnings Call
  13. Here's Why Athersys Is Soaring Today
  14. Athersys (ATHX) Upgraded to Strong Buy: Here's What You Should Know
  15. HEALIOS K.K. Announces Enrollment of First Patient in Japan in the ONE-BRIDGE Study of MultiStem® Treatment for Acute Respiratory Distress Syndrome
  16. Athersys to Host Investor Day in New York City
  17. Athersys to Host First Quarter Financial Results Call
  18. Edited Transcript of ATHX earnings conference call or presentation 14-Mar-19 8:30pm GMT
  19. What Makes Athersys (ATHX) a New Buy Stock